论文部分内容阅读
高脂血症是指体内脂质代谢紊乱引起血液中一种或多种脂质(主要是胆固醇和甘油三酯)成分含量的异常增高,是现代人尤其是中老年的常见病,血脂升高在40岁以上人群呈多发症、常见症,且有低龄化发展趋势[1]。以阿托伐他汀、非诺贝特为代表的降血脂药物每年数百亿美元的年销售额奠定
Hyperlipidemia refers to abnormal lipid metabolism in the body caused by one or more of the blood lipid (mainly cholesterol and triglycerides) abnormal increase in the content of the modern common disease, especially in the elderly, elevated blood lipids People over the age of 40 were multiple, common disease, and the development trend of younger age [1]. Lipid-lowering drugs represented by atorvastatin and fenofibrate are worth tens of billions of dollars in annual sales